---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-004612"
form_type: "8-K"
ticker: "DSGN"
cik: "0001807120"
company_name: "Design Therapeutics, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:43:46.883286+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Design Therapeutics updates corporate presentation with no material new information

## Summary
- Updated corporate presentation filed as Exhibit 99.1 for use in investor meetings.
- No financial results, clinical data, or guidance changes disclosed in the filing.
- Filing includes only the presentation; no other material events reported.
- This is a routine Regulation FD disclosure without specific new facts.

## SEC filing metadata
- accession: 0000950170-25-004612
- form_type: 8-K
- ticker: DSGN
- cik: 0001807120
- company_name: Design Therapeutics, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1807120/000095017025004612/0000950170-25-004612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1807120/000095017025004612/dsgn-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-004612
- JSON: https://secwatch.observer/filing/0000950170-25-004612.json
- Plain text: https://secwatch.observer/filing/0000950170-25-004612.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.